| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | Chief Scientific Officer | Common Shares | 42,333 | $57,150 | $1.35 | 21 Mar 2025 | Direct |
| ATAI Life Sciences N.V. | Chief Scientific Officer | Stock Option | 757,915 | 03 Mar 2025 | Direct | ||
| AtaiBeckley Inc. | Chief Scientific Officer | Stock Option | 675,000 | 30 Jan 2026 | Direct | ||
| AtaiBeckley Inc. | Chief Scientific Officer | Restricted Stock Units | 150,000 | 30 Jan 2026 | Direct | ||
| ATAI Life Sciences N.V. | Chief Scientific Officer | Restricted Stock Units | 0 | 14 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000114036126003548-short-glenn-frank-2026-01-30 | AtaiBeckley Inc. | 30 Jan 2026 | 2 | $0 | 4 | Chief Scientific Officer | 03 Feb 2026, 18:54 |
| ATAI | ATAI Life Sciences N.V. | 21 Mar 2025 | 1 | -$17,767 | 4 | Chief Scientific Officer | 24 Mar 2025, 21:00 |
| ATAI | ATAI Life Sciences N.V. | 14 Mar 2025 | 2 | $0 | 4 | Chief Scientific Officer | 19 Mar 2025, 19:29 |
| ATAI | ATAI Life Sciences N.V. | 03 Mar 2025 | 1 | $0 | 4 | Chief Scientific Officer | 06 Mar 2025, 09:10 |
| ATAI | ATAI Life Sciences N.V. | 01 Jan 2025 | 0 | $0 | 3 | Chief Scientific Officer | 10 Jan 2025, 16:15 |